Pharmacokinetics of Nadolol in Children with Supraventricular Tachycardia

The pharmacokinetics of intravenous and oral nadolol, a long‐acting β‐adrenoceptor blocking agent, were investigated in six children receiving the drug for treatment of supraventricular tachycardia. In the youngest patient (age 3 months), no distribution phase was seen. In children younger than 22 m...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of clinical pharmacology 1992-11, Vol.32 (11), p.1023-1027
Hauptverfasser:	Mehta, Ashok V., Chidambaram, Balasubrahmanyam, Rice, Peter J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Antiarythmic agents Biological and medical sciences Cardiovascular system Child Child, Preschool Humans Infant Medical sciences Nadolol - pharmacokinetics Nadolol - therapeutic use Pharmacology. Drug treatments Tachycardia, Supraventricular - drug therapy Tachycardia, Supraventricular - metabolism
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!